Literature DB >> 28923814

New Method for Real Time Influenza Surveillance in Primary Care: A Wisconsin Research and Education Network (WREN) Supported Study.

Jonathan L Temte1, Shari Barlow2, Amber Schemmel2, Emily Temte2, David L Hahn2, Erik Reisdorf2, Peter Shult2, John Tamerius2.   

Abstract

INTRODUCTION: The goal of public health infectious disease surveillance systems is to provide accurate laboratory results in near-real time. When it comes to influenza surveillance, most current systems are encumbered with inherent delays encountered in the real-life chaos of medical practice. To combat this, we implemented and tested near-real-time surveillance using a rapid influenza detection test (RIDT) coupled with immediate, wireless transmission of results to public health entities.
METHODS: A network of 19 primary care clinics across Wisconsin were recruited, including 4 sites already involved in ongoing influenza surveillance and 15 sites that were new to surveillance activities. Each site was provided with a Quidel Sofia Influenza A+B RIDT analyzer attached to a wireless router. Influenza test results, along with patient age, were transmitted immediately to a cloud-based server, automatically compiled, and forwarded to the surveillance team daily. Weekly counts of positive influenza A and B cases were compared with positive polymerase chain reaction (PCR) detections from an independent surveillance system within the state.
RESULTS: Following Institutional Review Board (IRB) and institutional approvals, we recruited 19 surveillance sites, installed equipment, and trained staff within 4 months. Of the 1119 cases tested between September 15, 2013 and June 28, 2014, 316 were positive for influenza. The system provided early detection of the influenza outbreak in Wisconsin. The influenza peak between January 12 and 25, 2014, as well as the epidemic curve, closely matched that derived from the established PCR laboratory network (r = 0.927; P < .001).
CONCLUSIONS: A network of influenza RIDTs with wireless transmission of results approximated the long-sought-after goal of real-time influenza surveillance. Results from the initial year strongly support this approach to highly accurate and timely influenza surveillance. © Copyright 2017 by the American Board of Family Medicine.

Entities:  

Keywords:  Communicable Diseases; Disease Outbreaks; Influenza; Polymerase Chain Reaction; Practice-based Research; Primary Health Care; Public Health Surveillance; Wisconsin

Mesh:

Year:  2017        PMID: 28923814     DOI: 10.3122/jabfm.2017.05.170031

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

Review 1.  Influenza surveillance systems using traditional and alternative sources of data: A scoping review.

Authors:  Aspen Hammond; John J Kim; Holly Sadler; Katelijn Vandemaele
Journal:  Influenza Other Respir Viruses       Date:  2022-09-08       Impact factor: 5.606

2.  Assessment of potential factors associated with the sensitivity and specificity of Sofia Influenza A+B Fluorescent Immunoassay in an ambulatory care setting.

Authors:  Cristalyne Bell; Maureen Goss; Jennifer Birstler; Emily Temte; Guanhua Chen; Peter Shult; Erik Reisdorf; Thomas Haupt; Shari Barlow; Jonathan Temte
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.752

3.  Novel Use of Rapid Antigen Influenza Testing in the Outpatient Setting To Provide an Early Warning Sign of Influenza Activity in the Emergency Departments of an Integrated Health System.

Authors:  Paige M K Larkin; Vladimir Manuel; Naureen Hernandez; Omai B Garner
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

4.  Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016.

Authors:  Ashley L Fowlkes; Andrea Steffens; Carrie Reed; Jonathan L Temte; Angela P Campbell
Journal:  Open Forum Infect Dis       Date:  2019-04-26       Impact factor: 3.835

5.  Comparison of local influenza vaccine effectiveness using two methods.

Authors:  G K Balasubramani; Richard K Zimmerman; Heather Eng; Jason Lyons; Lloyd Clarke; Mary Patricia Nowalk
Journal:  Vaccine       Date:  2021-01-21       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.